- Home
- SPNS vs CNTA Comparison
SPNS vs CNTA Comparison
Compare SPNS & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPNS | CNTA |
|---|---|---|
| Founded | 1982 | 2020 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 1992 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPNS | CNTA |
|---|---|---|
| Price | $43.45 | $25.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $31.33 | ★ $37.70 |
| AVG Volume (30 Days) | 498.2K | ★ 1.8M |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $564,331,000.00 | $15,000,000.00 |
| Revenue This Year | $8.80 | N/A |
| Revenue Next Year | $6.98 | N/A |
| P/E Ratio | $37.80 | ★ N/A |
| Revenue Growth | 4.71 | ★ 118.88 |
| 52 Week Low | $23.69 | $9.60 |
| 52 Week High | $43.48 | $30.58 |
Technical Indicators
Market Signals| Indicator | SPNS | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 71.35 | 41.54 |
| Support Level | $43.27 | $25.59 |
| Resistance Level | $43.52 | $30.02 |
| Average True Range (ATR) | 0.06 | 1.31 |
| MACD | 0.00 | -0.58 |
| Stochastic Oscillator | 80.40 | 2.37 |
Price Performance
Historical ComparisonAbout SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.